JAMEE BALTZELL: Open Payments
NPI 1609159425 · OLNEY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 27 payments from 9 companies in 2025. Trend: 2023 $455 · 2024 $287 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Novo Nordisk Inc | 1 | $27 |
| Indivior Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $16 |
| Corium, LLC | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, Qelbree, Jornay PM, Wegovy, SUBLOCADE, ARISTADA.
Industry payments across IL — which companies pay providers there.
